Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: a randomized, double-blind, placebo-controlled study
These fats naturally increase GLP-1 levels and include: Monounsaturated fatty acid (MUFA) Omega-3 fatty acids These types of fats are found in foods like: Trout, Salmon, Mackerel, Anchovies, Herring, Sardines Avocado and avocado oil Olives and olive oil Flaxseeds and flaxseed oil In contrast, saturated fats and omega-6 fatty acids dont seem to increase GLP-1 levels as effectively
And when you have, in fact, GLP-1 receptors in regions of the brain, it can often tell you a bit about what its job description is

Common side effects reported in clinical trials include: Gastrointestinal disturbances : cramping, diarrhoea, flatulence, constipation, and abdominal discomfort are the most frequently reported adverse effects, occurring in up to 30% of users in some studies Nausea : particularly when starting treatment or taking higher doses These effects are typically mild to moderate and often improve with continued use or dose reduction Less common but important considerations : Berberine may cause a temporary increase in bilirubin levels, which could be problematic in individuals with liver disease Berberine should not be used during pregnancy or breastfeeding due to potential risks to the foetus or infant (including theoretical risk of kernicterus in infants) Berberine is not recommended for use in children or adolescents Allergic reactions, whilst rare, can occur Significant drug interactions are a major concern: Diabetes medications : Berberine may have additive glucose-lowering effects, particularly with insulin and sulphonylureas, increasing the risk of hypoglycaemia

The amount of weight you can lose with GLP-1 agonists varies based on factors like your baseline weight, diet, exercise habits and how your body reacts to the medication
Lets briefly look at the history